The New Frontier of Pharmaceuticals

A Community Health Forum | December 3, 2019

Biologics, specialty drugs, and cell and gene therapies are increasingly in the pipeline to change the face of rare and chronic diseases that were previously untreated. With new gene therapies ranging from $850,000 to $2.1 million, it is important to understand the pipeline for these breakthrough therapies and how patients and purchasers can afford them. According to a new analysis by Willis Towers Watson’s Rx Collaborative, employers spend 40% of their drug costs on less than 1% of prescriptions. Hear from experts on how to make these life-saving therapies available to patients while slowing the growth of the rising costs of drug spending.


  • Understand the new drug pipeline:
  • Understand the impact of these new therapies for key healthcare stakeholders
  • Understand the value and management strategies for these new pharmaceuticals
  • Understand how biosimilars if adopted can reduce spendinUnderstand Value-Based Drug Review Process to ensure there is value in selecting a drug
  • Understand Outcomes-Based Drug Contracting
  • Understand PBM and Specialty Drug management
  • Understand the latest benefit design modifications such as partial fills, step therapy, preferred pharmacy networks, prior authorizations, reference pricing, tiered deductibles, and price transparency

Guest Speaker

Amy Ball, Pharm D

Chief Pharmacy Officer | Health Strategy LLC

Panel Moderator

Diana Han, MD

Global Medical Director | GE Appliances, a Haier company


Tierra Ford, PharmD

Senior Clinical Professional | Specialty Client Solutions

CVS Health

Deborah Gan, MBA

Executive Director | Merck

Integrated Account Management | Strategic Insights

Dan Leonard

President and CEO | National Pharmaceutical Council

Date and Time

Tuesday, December 3, 2019
Breakfast: 7:30 a.m.
Program: 8 a.m. to 10:30 a.m.


Foundation for a Healthy Kentucky
1640 Lyndon Farm Ct. #100
Louisville, KY 40223

Our Community Health Forums are open to the public to educate healthcare stakeholders on emerging trends in healthcare transformation.